Gaixiang Xu

Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial

Huafeng Wang, Liping Mao, Min Yang et al. · The Lancet Haematology · 2022 · 97 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

Loss of expression of LyGDI (ARHGDIB), a rho GDP‐dissociation inhibitor, in Hodgkin lymphoma^*

Liya Ma, Gaixiang Xu, Anna Sotnikova et al. · British Journal of Haematology · 2007 · 45 citations · Full text

Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms

Xingnong Ye, Xinping Zhou, Juying Wei et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 31 citations

All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARα-Nrf2 complex

Lu Wang, Qi Zhang, Li Ye et al. · British Journal of Cancer · 2022 · 18 citations · Full text

Novel influenza A (H1N1) in patients with hematologic disease

Juying Wei, Feifei Chen, Jie Jin et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 11 citations

Pandemic H1n1 Virus, Viral Pathogenesis, Immunology +10